Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
6.25
+0.26 (4.34%)
Dec 20, 2024, 4:00 PM EST - Market closed
Design Therapeutics Employees
Design Therapeutics had 58 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
58
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$823,776
Market Cap
353.88M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58 | 0 | - |
Dec 31, 2022 | 58 | 20 | 52.63% |
Dec 31, 2021 | 38 | 23 | 153.33% |
Dec 31, 2020 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 748 |
Valneva SE | 676 |
Spok Holdings | 384 |
Kamada | 378 |
Prime Medicine | 234 |
NeuroPace | 171 |
Absci | 155 |
Contineum Therapeutics | 31 |
DSGN News
- 5 weeks ago - Design Therapeutics to Participate in Multiple Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio - GlobeNewsWire
- 4 months ago - Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio - GlobeNewsWire
- 8 months ago - Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones - GlobeNewsWire
- 8 months ago - Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 9 months ago - Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 10 months ago - Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update - GlobeNewsWire